Related Experiment Video
Updated: Jul 11, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Topiramate as treatment for hemifacial spasm
Hortensia Alonso-Navarro1, Lluisa Rubio, Félix Javier Jiménez-Jiménez
1Sección de Neurología, Hospital Virgen de la Concha, Zamora, Spain.
Objective:
To report a patient with hemifacial spasm (HFS) which improved with topiramate.
Case Report:
A 52-year-old woman diagnosed with migraine, who also had a right HFS, did experience a marked improvement of HFS after introduction of topiramate as prophylactic therapy for her migraine episodes. Topiramate withdrawal led to reappearance of HFS, which improved again after its reintroduction.
Conclusions:
Topiramate should be considered as a possible therapy for HFS.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...

